CD19(+) tumor-infiltrating B-cells prime CD4(+) T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer.
CD19(+) tumor-infiltrating B-cells prime CD4(+) T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer.
复制标题
DOI：
10.1007/s00262-018-2250-9
复制
发表时间：
2018
期刊：
影响因子：
--
通讯作者：
Xu J
中科院分区：
文献类型：
--
作者：
Jiang Q;Fu Q;Chang Y;Liu Z;Zhang J;Xu L;Zhu Y;Wang Y;Zhang W;Xu J
